153 related articles for article (PubMed ID: 28952876)
1. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
2. Conformational variants of the ternary complex of C5a, C5aR1, and G-protein.
Gupta PK; Singh A; Rana S
J Biomol Struct Dyn; 2024 Jan; ():1-16. PubMed ID: 38247266
[TBL] [Abstract][Full Text] [Related]
3. Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages.
Wu KC; Condon ND; Hill TA; Reid RC; Fairlie DP; Lim J
J Innate Immun; 2023; 15(1):468-484. PubMed ID: 36882040
[TBL] [Abstract][Full Text] [Related]
4. C5a-C5aR1 Axis Activation Drives Envenomation Immunopathology by the Snake
Silva de França F; Villas-Boas IM; Cogliati B; Woodruff TM; Reis EDS; Lambris JD; Tambourgi DV
Front Immunol; 2021; 12():652242. PubMed ID: 33936074
[TBL] [Abstract][Full Text] [Related]
5. Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression.
Carvalho K; Schartz ND; Balderrama-Gutierrez G; Liang HY; Chu SH; Selvan P; Gomez-Arboledas A; Petrisko TJ; Fonseca MI; Mortazavi A; Tenner AJ
J Neuroinflammation; 2022 Jul; 19(1):178. PubMed ID: 35820938
[TBL] [Abstract][Full Text] [Related]
6. Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis.
Sommerfeld O; Medyukhina A; Neugebauer S; Ghait M; Ulferts S; Lupp A; König R; Wetzker R; Schulz S; Figge MT; Bauer M; Press AT
Mol Ther; 2021 Jan; 29(1):338-346. PubMed ID: 32966769
[TBL] [Abstract][Full Text] [Related]
7. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
Li XX; Kumar V; Clark RJ; Lee JD; Woodruff TM
Front Pharmacol; 2020; 11():591398. PubMed ID: 33551801
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Characterization of a New Class of C5aR1 Antagonists Showing
Hubler F; Renneberg D; Siendt H; Stamm S; Hilpert K; Caroff E; Delahaye S; Froidevaux S; Murphy MJ
J Med Chem; 2024 Mar; 67(5):4100-4119. PubMed ID: 38482828
[TBL] [Abstract][Full Text] [Related]
9. C5a/C5aR1 axis as a key driver promotes epithelial-to-mesenchymal transition in airway epithelial cells in silica nanoparticles-induced pulmonary fibrosis.
Zhou S; Wang Z; Gao L; Chen M; Duan Y; Zhou P; Liu Z; Wu C; Zhang J; Zhu Q
Int Immunopharmacol; 2023 Dec; 125(Pt B):111112. PubMed ID: 37948857
[TBL] [Abstract][Full Text] [Related]
10. Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays
Gorman DM; Li XX; Payne CD; Cui CS; Lee JD; Rosengren KJ; Woodruff TM; Clark RJ
ACS Pharmacol Transl Sci; 2021 Dec; 4(6):1808-1817. PubMed ID: 34927012
[TBL] [Abstract][Full Text] [Related]
11. C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages.
Serfecz JC; Saadin A; Santiago CP; Zhang Y; Bentzen SM; Vogel SN; Feldman RA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576075
[TBL] [Abstract][Full Text] [Related]
12. The C5aR1 complement receptor: A novel immunomodulator of insulin action in skeletal muscle.
Shah DS; McNeilly AD; McCrimmon RJ; Hundal HS
Cell Signal; 2024 Jan; 113():110944. PubMed ID: 37890688
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.
Yatime L; Maasch C; Hoehlig K; Klussmann S; Andersen GR; Vater A
Nat Commun; 2015 Apr; 6():6481. PubMed ID: 25901944
[TBL] [Abstract][Full Text] [Related]
14. Complement C5a Receptor Signaling Alters Stress Responsiveness and Modulates Microglia Following Chronic Stress Exposure.
Chen HC; Spiers JG; Lerskiatiphanich T; Parker SE; Lavidis NA; Fung JN; Woodruff TM; Lee JD
Biol Psychiatry Glob Open Sci; 2024 May; 4(3):100306. PubMed ID: 38628385
[TBL] [Abstract][Full Text] [Related]
15. Cell-intrinsic C5a synergizes with Dectin-1 in macrophages to mediate fungal killing.
Li XX; Fung JN; Clark RJ; Lee JD; Woodruff TM
Proc Natl Acad Sci U S A; 2024 Jan; 121(5):e2314627121. PubMed ID: 38252818
[TBL] [Abstract][Full Text] [Related]
16. Active immunotherapy for C5a-mediated inflammation using adjuvant-free self-assembled peptide nanofibers.
Hainline KM; Haddad HF; Gilpin A; Curvino EJ; Varghese S; Collier JH
Acta Biomater; 2024 Apr; 179():83-94. PubMed ID: 38447809
[TBL] [Abstract][Full Text] [Related]
17. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
Beach C; MacLean D; Majorova D; Melemenidis S; Nambiar DK; Kim RK; Valbuena GN; Guglietta S; Krieg C; Darvish-Damavandi M; Suwa T; Easton A; Hillson LV; McCulloch AK; McMahon RK; Pennel K; Edwards J; O'Cathail SM; Roxburgh CS; Domingo E; Moon EJ; Jiang D; Jiang Y; Zhang Q; Koong AC; Woodruff TM; Graves EE; Maughan T; Buczacki SJ; Stucki M; Le QT; Leedham SJ; Giaccia AJ; Olcina MM
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37824211
[TBL] [Abstract][Full Text] [Related]
18. C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.
Perrino MR; Ahmari N; Hall A; Jackson M; Na Y; Pundavela J; Szabo S; Woodruff TM; Dombi E; Kim MO; Köhl J; Wu J; Ratner N
Life Sci Alliance; 2024 May; 7(5):. PubMed ID: 38458648
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors.
Yadav MK; Maharana J; Yadav R; Saha S; Sarma P; Soni C; Singh V; Saha S; Ganguly M; Li XX; Mohapatra S; Mishra S; Khant HA; Chami M; Woodruff TM; Banerjee R; Shukla AK; Gati C
Cell; 2023 Oct; 186(22):4956-4973.e21. PubMed ID: 37852260
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking.
Kanhasut K; Tharakaraman K; Ruchirawat M; Satayavivad J; Fuangthong M; Sasisekharan R
Sci Rep; 2022 Aug; 12(1):14754. PubMed ID: 36042241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
